Skip to main content
Premium Trial:

Request an Annual Quote

Agilent Collaborating with Florey Institute on Mass Spec Methods for Study of Metalloproteins

Premium

Agilent said this week that it will collaborate with Australia's Florey Institute of Neuroscience and Mental Health on methods for measuring metals at the protein level in tissue affected by neurodegenerative diseases including motor neuron, Parkinson's, and Alzheimer's.

The collaboration will focus on developing techniques for improved measurement of metalloproteins via liquid chromatography combined with Agilent's 7700 ICP-MS instrumentation. These techniques will allow Florey researchers to compare metalloprotein levels in samples of interest and investigate the range of metalloproteins present in these samples.

While metals and metalloproteins are thought to play a role in neurodegenerative processes, researchers have little data on how changes in the level of metals like copper, iron, and zinc at the protein level translate to changes in cellular function or disease state.

"This is an important breakthrough for the scientific community as we push forward for more effective treatments for a range of neurological and psychiatric conditions," Blaine Roberts, senior research scientist at the Florey, said in a statement.

"We are very excited about this collaboration, as it matches the leading-edge brain research of the Florey and Agilent's leading-edge technologies," said Rod Minett, general manager of Agilent's Life Sciences Group in South Korea and the South Asia-Pacific region. "The emerging field of metalloproteins will help us better understand the human brain and could potentially lead to better clinical outcomes for patients."

Financial and other terms of the agreement were not disclosed.

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.